Literature DB >> 1722197

Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.

T Land1, U Langel, M Löw, M Berthold, A Undén, T Bartfai.   

Abstract

The neuropeptide galanin (1-29) binds with high affinity to hypothalamic receptors (KD approximately 0.9 nM) and regulates feeding behavior. The N-terminal fragments (1-16), (1-16)NH2 are high affinity (KD approximately 6 nM) full agonists in vivo and in vitro. L-Ala substitutions show that amino acid residues Gly1, Trp2, Asn5, Tyr9, and Gly12 are important for the high affinity binding of galanin (1-16). Shortening the fragment (1-16) to galanin (1-7) causes a gradual drop of affinity: galanin (1-15), (1-14), and (1-13) have submicromolar KD values and galanin (1-12) has KD approximately 3 microM. Cyclic analogs of galanin (1-12) of different ring size were synthesized by condensing Gly1 and Gly12 without or with spacer groups. These analogs, independent of ring size, had a lower affinity than the linear galanin (1-12). Derivatization of the N-terminus of galanin (1-29), (1-16), and (1-12) all resulted in a large drop of affinity for the receptors, suggesting again the importance of the free N-terminal Gly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722197     DOI: 10.1111/j.1399-3011.1991.tb01438.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  21 in total

1.  Generating orally active galanin analogues with analgesic activities.

Authors:  Charles R Robertson; Timothy H Pruess; Erin Grussendorf; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2012-02-28       Impact factor: 3.466

2.  Synthesis of galmic: a nonpeptide galanin receptor agonist.

Authors:  Susana Conde Ceide; Laurent Trembleau; Gebhard Haberhauer; Laszlo Somogyi; Xiaoying Lu; Tamas Bartfai; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

3.  Prediction of conformation of rat galanin in the presence and absence of water with the use of Monte Carlo methods and the ECEPP/3 force field.

Authors:  A Liwo; S Ołdziej; J Ciarkowski; G Kupryszewski; M R Pincus; R J Wawak; S Rackovsky; H A Scheraga
Journal:  J Protein Chem       Date:  1994-05

4.  Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus.

Authors:  G A Kinney; P J Emmerson; R J Miller
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

Review 5.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 6.  Positive allosteric modulators to peptide GPCRs: a promising class of drugs.

Authors:  Tamas Bartfai; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

Review 7.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

8.  Alarin stimulates food intake and gonadotrophin release in male rats.

Authors:  C K Boughton; M Patterson; G A Bewick; J A Tadross; J V Gardiner; K E L Beale; F Chaudery; G Hunter; M Busbridge; E M Leavy; M A Ghatei; S R Bloom; K G Murphy
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

9.  A short estrogen-responsive N-terminal galanin homologue found in rat brain and gut with antiserum raised against rat galanin(1-16).

Authors:  Susanne Hilke; Tomas Hökfelt; Elvar Theodorsson
Journal:  Neurochem Res       Date:  2006-04-04       Impact factor: 3.996

10.  Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.

Authors:  D Wynick; D M Smith; M Ghatei; K Akinsanya; R Bhogal; P Purkiss; P Byfield; N Yanaihara; S R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.